3 results
Approved WMOWill not start
The objective of this study is to assess the safety and feasibility of the Doraya Catheter in the treatment of subjects hospitalized with congestive AHF, with insufficient response to diuretic therapy.
Approved WMORecruiting
The current trial aims to demonstrate that sugammadex is generally safe and effective for reversing both moderate and deep block after rocuronium or vecuronium induced NMB in term neonates and young children.
Approved WMOCompleted
To characterize the safety, tolerability, and recommended phase 2 dose (RP2D) of each combination partner used with ruxolitinib (Part 1)To evaluate the preliminary efficacy of each novel ruxolitinib combination treatment arm (Parts 2 & 3)